Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4351
Cabaletta Bio
CABA
$437M
| $78.2K | ﹤0.01% |
56,438
-15,179
| -21% | -$32.3K |
|
|
CTNM
4352
Contineum Therapeutics
CTNM
$583M
| $77.4K | ﹤0.01% |
11,083
-5,203
| -32% | -$47.3K |
|
4353
Jasper Therapeutics
JSPR
$21M
| $77.2K | ﹤0.01% |
17,960
-374
| -2% | -$2.49K |
|
4354
1stdibs.com
DIBS
$149M
| $77K | ﹤0.01% |
25,338
-14,854
| -37% | -$53.3K |
|
|
MPX
4355
DELISTED
Marine Products Corp
MPX
| $76.9K | ﹤0.01% |
9,166
-4,358
| -32% | -$38.4K |
|
4356
QuickLogic
QUIK
$232M
| $76.5K | ﹤0.01% |
14,977
-6,857
| -31% | -$51.5K |
|
4357
Direxion Daily NVDA Bull 2X ETF
NVDU
$551M
| $76.3K | ﹤0.01% |
1,450
| – | – |
|
4358
WisdomTree Artificial Intelligence and Innovation Fund
WTAI
$587M
| $76K | ﹤0.01% |
4,000
| – | – |
|
4359
Vanguard Financials ETF
VFH
$13.5B
| $76K | ﹤0.01% |
636
-184,465
| -100% | -$22.5M |
|
|
KEEL
4360
Keel Infrastructure Corp
KEEL
$2.4B
| $76K | ﹤0.01% |
96,374
+14,682
| +18% | +$19.5K |
|
|
GOOS
4361
Canada Goose Holdings
GOOS
$872M
| $75.9K | ﹤0.01% |
9,549
-77
| -0.8% | -$759 |
|
4362
iShares MSCI Europe Small-Cap ETF
IEUS
$180M
| $75.7K | ﹤0.01% |
1,320
| – | – |
|
4363
Sutro Biopharma
STRO
$401M
| $75.7K | ﹤0.01% |
11,629
-4,252
| -27% | -$67K |
|
4364
ProShares Ultra Financials
UYG
$828M
| $75.4K | ﹤0.01% |
846
| – | – |
|
4365
Waldencast
WALD
$222M
| $75K | ﹤0.01% |
25,014
-12,328
| -33% | -$39.9K |
|
4366
Acme United Corp
ACU
$217M
| $74.9K | ﹤0.01% |
1,892
-2,550
| -57% | -$95.9K |
|
4367
Janus Henderson AAA CLO ETF
JAAA
$29B
| $74.2K | ﹤0.01% |
1,464
+794
| +119% | +$40.3K |
|
4368
RCM Technologies
RCMT
$201M
| $74.1K | ﹤0.01% |
4,753
-5,652
| -54% | -$106K |
|
4369
Rekor Systems
REKR
$85.8M
| $74.1K | ﹤0.01% |
83,555
-33,060
| -28% | -$52.2K |
|
4370
NLI Holdings
NL
$281M
| $73.9K | ﹤0.01% |
9,355
-4,183
| -31% | -$31.1K |
|
4371
FT Vest US Equity Deep Buffer ETF May
DMAY
$375M
| $73.8K | ﹤0.01% |
1,864
-674
| -27% | -$27.6K |
|
4372
FT Vest US Equity Buffer ETF May
FMAY
$1.41B
| $73.8K | ﹤0.01% |
1,598
-2,617
| -62% | -$125K |
|
4373
Destination XL Group
DXLG
$31.2M
| $73.6K | ﹤0.01% |
50,426
-30,172
| -37% | -$70.6K |
|
|
PAMT
4374
PAMT Corp
PAMT
$337M
| $73.1K | ﹤0.01% |
6,023
-3,009
| -33% | -$43.4K |
|
|
MGIC
4375
DELISTED
Magic Software Enterprises
MGIC
| $72.9K | ﹤0.01% |
5,614
-140
| -2% | -$1.79K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.